Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
62.94
-0.20 (-0.32%)
At close: Dec 5, 2025
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 29.03 billion as of December 5, 2025. Its market cap has increased by 47.58% in one year.
Market Cap
29.03B
Enterprise Value
28.17B
Revenue
607.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
62.94
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 29.03B, an increase of 76.56%. That is a compound annual growth rate of 15.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 29.03B | 68.40% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 404.96B |
| WuXi AppTec | 267.37B |
| Shenzhen Mindray Bio-Medical Electronics | 241.27B |
| Sichuan Biokin Pharmaceutical | 149.34B |
| Shanghai United Imaging Healthcare | 105.68B |
| Aier Eye Hospital Group | 104.39B |
| Zhangzhou Pientzehuang Pharmaceutical., | 103.46B |
| Yunnan Baiyao Group Co.,Ltd | 99.40B |